EXHIBIT 107
Calculation of Filing Fee Tables
S-8
(Form Type)
TG Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
Security Type |
| Security |
| Fee |
| Amount Registered |
| Proposed |
| Maximum |
| Fee Rate |
| Amount of | ||||
Equity | Common Stock, par value $0.001 | 457(h) | 17,000,000 | (1) | $ | 3.645 | (2) | $ | 61,965,000 | (2) | 0.0000927 | $ | 5,744.16 | |||||
Total Offering Amounts | $ | 61,965,000 | (2) | $ | 5,744.16 | |||||||||||||
Total Fee Offsets | ||||||||||||||||||
Net Fee Due | $ | 5,744.16 | ||||||||||||||||
(1) | Represents 17,000,000 shares that may be issued under the TG Therapeutics, Inc. 2022 Incentive Plan (the “Plan”), including additional shares that may become issuable in accordance with the adjustment and anti-dilution provisions of the Plan. |
(2) | Determined in accordance with Rule 457(h) under the Securities Act of 1933, as amended, solely for the purpose of calculating the registration fee, based on the average of the high and low prices of $3.81 and $3.48, respectively, of the Company’s Common Stock reported on the Nasdaq Capital Market on June 16, 2022. |
